CIMIT's Listing of External Grants and Funding Opportunities

Grants
Types of Grants
How to Apply
Grant Forms
Request for Applications Key Dates
External Funding Opportunities
Funding Resource Sites

External Funding News Releases

1.7.10
Department of Defense Neurofibromatosis Research Program
Funding Opportunities for Fiscal Year 2010

The biggest value of CIMIT is the ability to generate preliminary data for future grant applications. It can be difficult to get cutting edge and innovative work funded without some form of supporting data, and CIMIT's early stage investments have really paid off.

* CIMIT and all affiliated entities do not endorse the information from external links, nor are they responsible for the availability, accuracy, or content of these sites.

External Grants and Funding Opportunities:

Print this Page
Request for Applications

A current listing* of external grants and government funding opportunities identified as relevant to the CIMIT community.

Grants are listed in cronological order of application submission opening/due dates.
Grants marked New! are recent additions to the page.

(Page last updated: 2/8/10, 33 New Funding Opportunities Added)

Harvard Catalyst and InnoCentive Prize for Innovation Contest

Submission Window: February 1, 2010 - March 1, 2010

Website: Innocentive.com posting

Purpose: Using federal stimulus funding from the National Institutes of Health, Harvard Catalyst is collaborating with InnoCentive, a global web community for open innovation, to launch a series of contests aimed at investigating whether new approaches increasingly popular in the private sector might be useful in sparking new research directions and collaborations in the academic healthcare community.

In their first contest, Harvard Catalyst and InnoCentive invite both the Harvard community and the network of InnoCentive solvers to propose new questions and ideas related to Type 1 diabetes. "This challenge is an exercise in tapping the knowledge of the widest possible community and encouraging the formation of new teams and new forms of collaboration around a specific topic area," said Dana-Farber Cancer Institute's Eva Guinan, MD, director of the Harvard Catalyst Linkages program and the other collaboration leader. "Type 1 diabetes is a good example of a disease that has touched many people at Harvard and elsewhere personally and professionally. As a result, they may have questions or ideas that could help spawn new collaborations and areas for research.”

Starting February 1, 2010, Harvard Catalyst and InnoCentive will accept testable, researchable questions and ideas about Type 1 diabetes - its biology, its progression, its clinical presentation, its complications, etc. The questions and ideas should be able to help define problems or new areas requiring exploration and research. All responses must be submitted by March 1, 2010. The people who submit the best questions or ideas, as determined by a review panel, will receive prizes of between $2,500 and $10,000.

National Science Foundation Biosensing Program

Application Submission Window: February 1, 2010 - March 3, 2010

Website: NSF.gov posting

Purpose: The Biosensing Program supports innovative, transformative, and insightful investigations of fundamental problems with broad long term impact and applications that require novel use of bio-inspired engineering principles and sophisticated devices to meet the engineering and technology needs of the nation. The program is targeting research in the area of the monitoring, identification, and/or quantification of biological phenomena and will support potential technological breakthroughs that exist at the intersection of engineering, life science, and information technology.

Projects submitted to the Program must advance both engineering and life sciences. Projects in the program may range from single investigator to multi-investigator collaborative research efforts.

The development of these novel principles and devices will require highly collaborative interactions between engineers, life scientists, and experts in nanotechnology, biomaterials, bioinformatics, and the chemical and physical sciences. The program recognizes the important role of education and workforce development specifically relevant to the multidisciplinary nature of the area of biosensing. Interdisciplinary teams are essential and must be fostered from discovery to application.

NSF Biophotonics, Advanced Imaging, and Sensing for Human Health Modification 2

Application Submission Window: February 1, 2010 - March 3, 2010

Website: Grants.gov posting

Purpose: Innovative basic research in photonics, imaging, and sensing that is very fundamental in science and engineering is needed to lay the foundation for new technologies beyond those that are mature and ready for application in medical diagnostics and therapies.

Developing molecularly specific sensing (molecular photonics), imaging, and monitoring systems with high sensitivity and resolution would be an enormous accomplishment with powerful applications to both biology and medicine. Low cost diagnostics will require novel integration of photonics, molecular biology, and material science. Complex biosensors capable of detecting and discriminating among large classes of biomolecules could be important not only to biology and medicine, but also to environmental sensing and homeland security.

The BISH program supports innovative research of biophotonic, imaging, and sensing technologies for applications in human health. Click here for examples of topics.

NSF Biomedical Engineering

Application Submission Window: February 1, 2010 - March 3, 2010

Website: Grants.gov posting

Purpose: The mission of the Biomedical Engineering (BME) Program is to

Provide opportunities to develop novel ideas into discovery-level and transformative projects that integrate engineering and life science principles in solving biomedical problems that serve humanity in the long-term
Advance both engineering and life sciences with biomedical engineering projects that are at the interface of engineering and biomedical sciences

The BME program supports fundamental, transformative, and discovery research applied to biological systems

NSF Biotechnology, Biochemical, and Biomass Engineering Modification 2

Application Submission Window: February 1, 2010 - March 3, 2010

Website: Grants.gov posting

Purpose: The Biotechnology, Biochemical, and Biomass Engineering (BBBE) program deals with fundamental problems involved in the processing and manufacturing of products of economic importance by effectively utilizing renewable resources of biological origin and bioinformatics originating from genomic and proteomic information.

The BBBE program emphasizes basic engineering and biological research that advances the fundamental knowledge base that contributes to a better understanding of cellular and biomolecular processes (in vivo, in vitro, and/or ex vivo) and eventually to the development of generic enabling technology and practical application.

Quantitative assessments of bioprocesses and their rates at the levels of gene regulation and expression, signal transduction pathways, posttranslational protein processing, enzymes in reaction systems, metabolic pathways, cells and tissues in cultivation, and biological systems including animal, plant, microbial and insect cells, etc. are considered vital to the successful research projects in the BBBE program.

NSF Biosensing

Application Submission Window: February 1, 2010 - March 3, 2010

Website: Grants.gov posting

Projects submitted to the Program must advance both engineering and life sciences. Projects in the program may range from single investigator to multi-investigator collaborative research efforts.

HHS Substance Abuse & Mental Health Services Adminis.
Projects to Deliver Peer-to-Peer Recovery Support Services Grant

Application Deadline: February 10, 2010

Website: SAMHSA.gov posting

Purpose: The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) announces the availability of FY 2010 funds for grants to deliver peer-to-peer recovery support services that help prevent relapse and promote sustained recovery from alcohol and drug use disorders. Successful applicants will provide peer-to-peer recovery support services that are responsive to community needs and strengths, and will carry out a performance assessment of these services.

RCSP is intended to support peer leaders from the recovery community in providing recovery support services to people in recovery and their family members, and to foster the growth of communities of recovery that will help individuals and families, achieve and sustain long-term recovery.

NIH. ARRA OS: Recovery Act 2009: Accelerating Adoption of Comparative Effectiveness Research Results by Providers and Patients (R18)

Application Submission Window: February 11 - March 11, 2010

Website: NIH posting

Purpose: This ASPE FOA, supported by funds provided to ASPE under the American Recovery and Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites grant applications from organizations that propose to develop and test interventions to improve the translation and adoption of existing comparative effectiveness research (CER) information and incorporate these findings into practice in both the public and private sectors. Doing so effectively would demonstrate a return on the CER investment, and, more importantly, improve the health of patients. Funds will be used to support organizations that 1) develop and implement evidence-informed and innovative CER-based adoption interventions targeting patients and/or providers; 2) develop proposals that test the implementation of CER-based adoption strategies within and across organizations and delivery systems and analyze any behavior change (in patients and/or providers) associated with the intervention. CER-based entails the applicant describing and justifying the existing comparative evidence that is the focus of the adoption intervention. Organizations applying for these funds will need to utilize existing or create new measurement systems to track adoption or adherence rates (thus measuring clinician and patient behavior changes) associated with the adoption of CER and measurement of health outcomes if possible. Applicants should also seek to understand the underlying factors associated with adoption.

NSF Engineering Design and Innovation

Application Deadline: February 15, 2010

Next Application Submission Windows: September 1, 2010 - October 1, 2010, Annually Thereafter; January 15, 2011 - February 15, 2011, Annually Thereafter

Website: NSF.gov posting

Purpose: The EDI program supports research leading to design theory and to tools and methods that enable implementation of the principles of design theory in the practice of design across the full spectrum of engineered products. The program focus is on gaining an understanding of the basic processes and phenomena underlying a holistic, life-cycle view of design where the total system life-cycle context recognizes the need for advanced understanding of the identification and definition of preferences, analysis of alternatives, effective accommodation of uncertainty in decision-making, and the relationship between data and knowledge in a digitally-supported process. The program funds advances in basic design theory, tools, and software to implement design theory and new design methods that span multiple domains, such as design for the environment and for manufacturability.

NIH Recovery Act Limited Competition: NIH Director’s Opportunity for Research in Five Thematic Areas (RC4)

Letters of Intent Deadline: February 15, 2010

Website: NIH posting

Purpose: This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, solicits through this limited competition applications from domestic (United States) institutions/organizations proposing to develop and implement critical research innovations in one or more of the following five thematic areas:

Applying Genomics and Other High Throughput Technologies
Translating Basic Science Discoveries into New and Better Treatments
Using Science to Enable Health Care Reform
Focusing on Global Health
Reinvigorating the Biomedical Research Community

This program is a trans-NIH effort supported by Recovery Act funds from the Office of the Director. Applicants may propose to address either a specific disease- or technology-related research question relevant to the mission of one or more participating Institutes and Centers, or propose the creation of a unique infrastructure/resource designed to accelerate scientific progress in the future.

NIH Exploratory Innovations in Biomedical Computational Science and Technology (R21)

Pre-Application Submission Deadline: February 16, 2010

Website: NIH posting

Purpose: The NIH is interested in promoting research and developments in biomedical informatics and computational biology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here, biomedical informatics and computational biology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational and mathematical research including the development of structural, functional, integrative, and analytical computational models and simulations.

NIH Exploratory/Developmental Bioengineering Research Grants (EBRG) [R21]

Application Deadline: February 16, 2010

Website: Grants.gov posting

Purpose: This Funding Opportunity Announcement (FOA) is intended to encourage innovation and high risk/impact bioengineering research in new areas. While minimal or no preliminary data are expected to be described in the application, applications should clearly indicate the significance of the proposed work and that the proposed research and/or development is scientifically sound, that the qualifications of the investigators are appropriate, and that resources available to the investigators are adequate. An EBRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research. The research proposed under this program can explore approaches and concepts new to a particular substantive area; research and development of new technologies, techniques or methods; or initial research and development of data upon which significant future research may be built.

NIH Behavioral & Integrative Treatment Development Program (R03)

Application Deadline: February 16, 2010

Website: NIH posting

Purpose: The purpose of this FOA for R03s is to encourage early career investigators or investigators who are striving to make a shift in their research to propose discrete, well-defined projects that can be completed within two years with limited resources. Projects of interest fall within the research domain of behavioral, combined, sequential, or integrated (behavioral/pharmacological) (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. Specific examples include: 1) Stage I pilot or feasibility studies; 2) secondary analysis of existing data; 3) small, self-contained research projects; 4) development of research assessments or methodology; and 5) development of new research technology.

NIH Behavioral & Integrative Treatment Development Program (R34)

Application Deadline: February 16, 2010

Website: NIH posting

Purpose: The purpose of this R34 Funding Opportunity Announcement (FOA) is to advance evidence-based treatment research through 1) the development, manualization, standardization, early-stage efficacy and/or pilot testing of novel or adapted treatments and/or interventions (i.e. Stage 1 treatment research, see below), 2) the refinement, modification, adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale efficacy or effectiveness trials, or 3) novel treatment research that requires preliminary testing or development. It is expected that research conducted via this R34 mechanism will primarily consist of Stage I treatment development research that will provide feasibility, tolerability, and acceptability information and/or pilot data for larger scale Stage II or Stage III behavioral and integrative treatment studies. This FOA seeks to support research, as described above, within the domains of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain.

DARPA Centers in Integrated Photonics Engineering Research (CIPhER)

Application Deadline: February 19, 2010

Website: DARPA.mil posting

Purpose: DARPA is soliciting innovative proposals for university research centers in the area of integrated photonics engineering. Proposed research should investigate innovative approaches that enable revolutionary advances in science, devices, or systems. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice.

New! NIH Recovery Act Limited Competition: Framework Programs for Global Health Signature Innovations Initiative (R24)

Letter of Intent Due: February 22, 2010

Website: NIH posting

Purpose: This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites applications from U.S. institutions and their partners to enhance the infrastructure and opportunities at the participating institutions for training postdoctoral investigators to carry out innovative, multidisciplinary research in Global Health. The initiative emphasizes hands on, problem solving, and collaborative approaches and may require the development of new training models and new partnerships within and beyond the university community.

New! NIH Recovery Act Limited Competition: Program to Enhance NIH-supported Global Health Research Involving Human Subjects (S07)

Letters of Intent Due: February 22, 2010

Website: NIH.gov posting

Purpose: This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites applications from U.S. institutions for one year of support for resources and activities that will strengthen oversight of NIH supported human subjects research conducted collaboratively with institutions in low- to middle-income countries (LMIC).

AHRQ Small Grant Program for Conference Support (R13)

Application Deadlines in 2010: February 22, April 20, June 21, August 20, October 20, December 20

Website: NIH posting

Purpose: The Agency for Healthcare Research and Quality (AHRQ), announces its continued interest in supporting conferences through its Small Grant Program for Conference Support. AHRQ seeks to support conferences that help to further its mission to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. The types of conferences eligible for support include: 1) Research development - conferences where issues or challenges in the practice and delivery of health care are defined and a research agenda or strategy for studying them is developed; 2) Research design and methodology - conferences where methodological and technical issues of major importance in the field of health services research are addressed or new designs and methodologies are developed; 3) Dissemination and implementation conferences - where research findings and evidence-based information and tools are summarized, communicated and used by organizations and individuals that have the capability to use the information to improve the outcomes, quality, access to, and cost and utilization of health care services; and/or, 4) Research training, infrastructure and career development -conferences where faculty, trainees and students are brought together with stakeholders to develop, share or disseminate research products, experiences, curricula, syllabi, training competencies.

New! DoD 2010.A Small Business Technology Transfer (STTR) Solicitation

Application Submission Window: February 23 - March 24, 2010

Website: DoD SBIR/STTR Program posting

Purpose: The Army and Navy, hereafter referred to as Department of Defense (DoD) Components, invite small business firms and research institutions to jointly submit proposals under this solicitation for the Small Business Technology Transfer (STTR) Program. The STTR Program is a program under which awards are made to small business concerns for cooperative research and development, conducted jointly by a small business and a research institution, through a uniform process having three phases. STTR, although modeled substantially on the Small Business Innovation Research (SBIR) Program, is a separate program and is separately financed. Subject to availability of funds, DoD Components will support high quality cooperative research and development proposals of innovative concepts to solve the listed defense-related scientific or engineering problems, especially those concepts that also have high potential for commercialization in the private sector.

The STTR Program is designed to provide a strong incentive for small companies and researchers at research institutions, i.e., non-profit research institutions, contractor-operated federally funded research and development centers (FFRDCs), and universities, to work together as a team to move ideas from the research institution to the marketplace, to foster high-tech economic development, and to address the technological needs of our armed forces. (See DoD's Critical Technology Areas).

NIH Shared Instrumentation Grant Program (S10)

Application Submission Window: February 23 - March 23, 2010

Website: NIH.gov posting

Purpose: The NCRR Shared Instrument Grant (SIG) program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instrumentation or an integrated system that costs at least $100,000. The maximum award is $600,000. Types of instruments supported include confocal and electron microscopes, biomedical imagers, mass spectrometers, DNA sequencers, biosensors, cell sorters, X-ray diffraction systems, and NMR spectrometers among others.

NIH Recovery Act Limited Competition: Institutional Comparative Effectiveness Research Mentored Career Development Award (KM1)

Application Submission Window: February 25 - March 25, 2010

Website: NIH.gov posting

Purpose: Through this Funding Opportunity Announcement (FOA), entitled “Institutional Comparative Effectiveness Research Mentored Career Development Award (KM1),” which is supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, the NIH invites applications from research-intensive institutions to support mentored career development in support of comparative effectiveness research (CER) in an interdisciplinary environment catering to the needs of diverse populations of scholars including (but not limited to) those with backgrounds in biostatistics, epidemiology, health economics, pharmacology, medicine, and dentistry. Scholars should be encouraged to register for higher degrees, where appropriate. Successful applicant institutions will be expected to include course development work in their proposal and make provision for expanding the pool of experienced CER mentors. This FOA is responsive to the NIH mission to build capacity in critical research areas http://www.nih.gov/about/index.html#mission.

New! AHRQ Improving Patient Safety through Simulation Research (R18)

Application Submission Window: February 26 - March 26, 2010

Website: NIH.gov posting

Purpose: The Agency for Healthcare Research and Quality (AHRQ) is interested in funding a diverse set of projects that develop, test and evaluate various simulation approaches for the purpose of improving the safe delivery of health care. Simulation in health care predominately is a training technique that exposes individuals and teams to realistic clinical challenges through the use of mannequins, task trainers, virtual reality, or standardized patients, and allows participants to experience in real-time the consequences of their decisions and actions. The principal advantage of simulation is that it provides a safe environment for health care practitioners to acquire valuable experience without putting patients at risk. Simulation also can be used as a test-bed to improve clinical processes and to identify failure modes or other areas of concern in new procedures and technologies that might otherwise be unanticipated and serve as threats to patient safety. Applications that address a variety of clinical settings are sought.

New! AHRQ Prevention and Management of Healthcare Associated Infections (R18)

Application Submission Window: March 1 - 29, 2010

Website: NIH.gov posting

Purpose: This funding opportunity announcement (FOA) solicits Research Demonstration (R18) Projects, and expresses AHRQ portfolio priority areas of interest for ongoing extramural health services research, demonstration, dissemination, and evaluation grants that propose to prevent and more effectively manage healthcare associated infections (HAIs).

NIH Independent Scientist in Global Health Award (ISGHA) (K02)

Application Deadline: March 1, 2010

Website: NIH.gov posting

Purpose: The purpose of the Independent Scientist Award in Global Health (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research in global health. The K02 award provides three, four, or five years of research and salary support, and “protected time” for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate.

New! CDMRP FY10 Prostate Cancer Research Program (PCRP) - Idea Development Award

Idea Development Award Pre-application Deadline: March 3, 2010

Website: CDMRP posting

Purpose: Supports new ideas that represent innovative, high-risk/high-gain approaches to prostate cancer research, and have the potential to make an important contribution to eliminating death and suffering from prostate cancer.

New! CDMRP FY10 Prostate Cancer Research Program (PCRP) - Synergistic Idea Development Award

Synergistic Idea Development Award Pre-application Deadline: March 3, 2010

Website: CDMRP posting

Purpose: Supports new or existing partnerships between two or three independent investigators to address a central innovative question in prostate cancer that may include high risk, provided there is a potential for significant impact.

PHS 2010-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])

Application Submission Window: March 5 - April 5, 2010

Website: NIH.gov posting

Purpose: This Funding Opportunity Announcement (FOA) issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and the Administration for Children and Families (ACF) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH, CDC, FDA and ACF awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2010-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, FDA and ACF.)

New! NIH NINDS Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows in MD-PhD programs (F31)

Application Submission Window: March 8 - April 13, 2010

Website: NIH.gov posting

Purpose: The purpose of this individual predoctoral research training fellowship is to provide support for promising doctoral candidates who are enrolled in combined MD-PhD programs, who will be performing dissertation research and training in scientific health-related fields relevant to the mission of the National Institute of Neurological Disorders and Stroke.

New! CDMRP FY10 Prostate Cancer Research Program (PCRP) - Exploration - Hypothesis Development Award

Exploration - Hypothesis Development Award Pre-application Deadline: March 10, 2010

Website: CDMRP posting

Purpose: Supports highly innovative, untested, potentially groundbreaking concepts in prostate cancer.

New! CDMRP FY10 Ovarian Cancer Research Program (OCRP) - Pilot Award

Pilot Award Pre-Application Submission Deadline: March 11, 2010

Website: CDMRP posting

Purpose: Supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer forward.

New! CDMRP FY10 Ovarian Cancer Research Program (OCRP) - Translational Pilot Award

Pilot Award Pre-Application Submission Deadline: March 11, 2010

Website: CDMRP posting

Purpose: Supports innovative translational research addressing a critical problem or question in ovarian cancer that will accelerate the movement of promising ideas toward clinical applications. Proposals are encouraged that specifically address critical needs of the ovarian cancer community in the following areas for the Translational Pilot Award only:

Initiation and precursor lesion of ovarian cancer
Novel approaches for the evaluation of predictive biomarkers
Understanding of the host and microenvironment
Novel imaging approaches for screening and management
Innovative insights into etiology and risk factors for ovarian cancer

New! CDMRP FY10 Peer Reviewed Medical Research Program (PRMRP) - Investigator-Initiated Research Award

Investigator-Initiated Research Award Pre-Application Submission Deadline: March 11, 2010

Website: CDMRP posting

Purpose: Supports military-relevant health-related research that will make an original and important contribution to a field of research or patient care. Supports research that is responsive to the health care needs of the Armed Forces, their family members, and/or the U.S. veteran population.

New! CDMRP FY10 Bone Marrow Failure Research Program (BMFRP) - New Investigator Award

New Investigator Award Pre-Application Submission Deadline: March 11, 2010

Website: CDMRP posting

Purpose: Supports the career transition and/or continued development of promising, independent, non-mentored investigators, who are in the early stages of their scientific careers in the field of BMF disease research. Must address an FY10 Topic Area. The FY10 PRMRP topic areas as provided by Congress are: Chronic Migraine and Post-traumatic Headache; Dystonia; Drug Abuse; Epilepsy; Fragile X Syndrome; Inflammatory Bowel Disease; Interstitial Cystitis; Listeria vaccine for infectious disease; Lupus; Mesothelioma; Neuroblastoma; Osteoporosis and related bone disease; Paget’s Disease; Pheochromocytoma; Polycystic Kidney Disease; Post-traumatic Osteoarthritis; Scleroderma; Social Work Research; Tinnitus.

New! NIH Scientific Meetings for Creating Interdisciplinary Research Teams (R13)

Application Submission Window: March 12 - April 12, 2010

Website: NIH.gov posting

Purpose: This FOA encourages Research Conference Grant (R13) applications from institutions and organizations that propose to develop interdisciplinary research teams. Teams must include investigators from the social and/or behavioral sciences, and may include the life and/or physical sciences. The goal is to broaden the scope of investigation into scientific problems, yield fresh and possibly unexpected insights, and increase the sophistication of theoretical, methodological, and analytical approaches by integrating the analytical strengths of two or more disparate scientific disciplines while addressing gaps in terminology, approach, and methodology. This program will allow investigators from multiple disciplines to hold meetings in order to provide the foundation for developing interdisciplinary research projects.

New! CDMRP FY10 Prostate Cancer Research Program (PCRP) - Impact Award

Impact Award Pre-application Deadline: March 17, 2010

Website: CDMRP posting

Purpose: Supports high-impact studies toward reducing or eliminating the problem of overtreatment of primary prostate cancer. Areas of interest include but are not limited to active surveillance, biomarkers, improved staging and grading (including imaging), optimal measures for decision making pre- and post biopsy, optimal measures for follow-up and assessment of progression, and cancer care outcomes research (e.g., quality of life, survivorship) and surveillance.

New! CDMRP FY10 Breast Cancer Research Program (BCRP) - Multi-Team Award

Clinical Trial Award Pre-Application Submission Deadline: March 18, 2010

Website: CDMRP posting

Purpose: Supports three innovative investigators and their research teams in a coordinated and integrated translational research effort to address a question of major importance in breast cancer.

New! CDMRP FY10 Breast Cancer Research Program (BCRP) - Transformative Vision Award

Transformative Vision Award Pre-Application Submission Deadline: March 18, 2010

Website: CDMRP posting

Purpose: Supports research programs that have an extraordinary vision for dramatically transforming the prevention or treatment of breast cancer and a plan to test and implement the vision as quickly as possible. Focuses on achieving a visionary solution to a problem or question of overarching importance to breast cancer through an investigator-defined approach.

New! CDMRP FY10 Breast Cancer Research Program (BCRP) - Inter-Institutional Training Award

Inter-Institutional Training Award Pre-Application Submission Deadline: March 18, 2010

Website: CDMRP posting

Purpose: Supports two or more faculty-level investigators at an organization that does not currently have a breast cancer research program to acquire mentored training in breast cancer research. Supports the establishment of a sustainable breast cancer research program at the applicant organization. Proposed research and training should lead to publication(s) and independent breast cancer research funding.

New! CDMRP FY10 Breast Cancer Research Program (BCRP) - Predoctoral Traineeship Award

Predoctoral Traineeship Award Pre-Application Submission Deadline: March 24, 2010

Website: CDMRP posting

Purpose: Supports the training of promising graduate students studying breast cancer research under the guidance of a designated mentor. The predoctoral trainee is considered the PI and should write the proposal with appropriate direction from the mentor. Training program and mentorship should facilitate development of the PI as a breast cancer researcher.

New! CDMRP FY10 Breast Cancer Research Program (BCRP) - Postdoctoral Fellowship Award

Postdoctoral Fellowship Award Pre-Application Submission Deadline: March 24, 2010

Website: CDMRP posting

Purpose: Supports the training of exceptionally talented recent doctoral graduates. Proposed research should be innovative and have the potential for high impact. Multidisciplinary training encouraged. Training program and mentorship should prepare the PI for an independent career at the forefront of breast cancer research.

New! CDMRP FY10 Peer Reviewed Medical Research Program (PRMRP) - Concept Award

Concept Award Pre-Application Submission Deadline: March 25, 2010

Website: CDMRP posting

Purpose: Supports the exploration of a highly innovative new concept or untested theory. Must address an FY10 Topic Area. The FY10 PRMRP topic areas as provided by Congress are: Chronic Migraine and Post-traumatic Headache; Dystonia; Drug Abuse; Epilepsy; Fragile X Syndrome; Inflammatory Bowel Disease; Interstitial Cystitis; Listeria vaccine for infectious disease; Lupus; Mesothelioma; Neuroblastoma; Osteoporosis and related bone disease; Paget’s Disease; Pheochromocytoma; Polycystic Kidney Disease; Post-traumatic Osteoarthritis; Scleroderma; Social Work Research; Tinnitus.

New! CDMRP FY10 Bone Marrow Failure Research Program (BMFRP) - Exploration–Hypothesis Development Award

Exploration–Hypothesis Development Award Pre-Application Submission Deadline: March 25, 2010

Website: CDMRP posting

Purpose: Supports initial exploration of innovative, untested, high-risk, potentially high-gain, and possibly groundbreaking concept.

New! CDMRP FY10 Multiple Sclerosis Research Program (MSRP) - Idea Award

Idea Award Pre-Application Submission Deadline: March 25, 2010

Website: CDMRP posting

Purpose: Supports conceptually innovative, high-risk/potentially high-reward research that could ultimately lead to critical discoveries toward understanding the causes and progression of MS and/or improvements in patient care and/or quality of life.

New! CDMRP FY10 Multiple Sclerosis Research Program (MSRP) - Concept Award

Concept Award Pre-Application Submission Deadline: March 25, 2010

Website: CDMRP posting

Purpose: Supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to MS.

New! CDC Prevention of Suicidal Behavior through the Enhancement of Connectedness (U01)

Letter of Intent Due: March 29, 2010

Website: Grants.gov posting (link available after 2/10/10 due to system maintenance)

New! NIH Parkinson’s Disease Data Organizing Center [PD-DOC] (U24)

Letter of Intent Due: March 30, 2010

Website: NIH.gov posting

Purpose: This FOA issued by the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, solicits cooperative agreement grant applications from institutions/organizations that propose to develop a redesigned and enhanced Parkinson’s Disease Data Organizing Center. NINDS and NIEHS are committed to facilitating the collection and sharing of data related to clinical and translational research in Parkinson’s disease. The goal of this program is a resource that will serve the Parkinson’s disease (PD) research community by developing an ongoing repository for data from clinical trials and clinical studies, including epidemiologic and genetic studies, related to PD, and sharing of these data to enhance research. These data may include clinical as well as associated imaging, genetic, and neuropathology data elements. In addition, the Center will link clinical data with associated genetic, biospecimen, imaging, and neuropathology data as available in other databases. The Parkinson’s Disease Data Organizing Center also will develop a flexible web-based data entry system using standardized common data elements for PD clinical research studies that can be modified by investigators for a variety of clinical research studies. The center will also maintain an up-to-date listing of resources for researchers in the scientific community. Ongoing outreach efforts should be undertaken to maximize data sharing via this resource in order to optimize research in PD. The information technology employed should serve to optimize the accessibility and usefulness of the information within the data organizing center.

Innovations in Biomedical Computational Science and Technology Initiative (SBIR [R43/R44])

Pre-Application Submission Deadline: April 5, 2010

Website: Grants.gov posting

Purpose: This funding opportunity announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose innovative research in biomedical informatics and computational biology to promote the progress of biomedical research. There exists an expanding need to speed the progress of biomedical research through the power of computing to manage and analyze data and to model biological processes. The NIH is interested in promoting research and developments in biomedical computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational research including the development of structural, functional, integrative, and analytical computational models and simulations.

Innovations in Biomedical Computational Science and Technology Initiative (STTR [R41/R42])

Pre-Application Submission Deadline: April 5, 2010

Website: Grants.gov posting

Purpose: Purpose This funding opportunity announcement (FOA) solicits Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose innovative research in biomedical informatics and computational biology to promote the progress of biomedical research. There exists an expanding need to speed the progress of biomedical research through the power of computing to manage and analyze data and to model biological processes. The NIH is interested in promoting research and developments in biomedical computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational research including the development of structural, functional, integrative, and analytical computational models and simulations.

NIH Brain Disorders in the Developing World: Research Across the Lifespan (R21)

Letters of Intent Receipt Date(s):
Applications not related to HIV/AIDS: April 14, 2010.
HIV/AIDS-related Applications: July 23, 2010

Website: Grants.gov posting

Purpose: This Funding Opportunity Announcement (FOA) encourages exploratory/developmental planning grant applications proposing the development of innovative, collaborative research and research training projects, between high income country (HIC) and low- to middle-income country (LMIC) scientists, on brain and other nervous system function and disorders throughout life, relevant to LMICs. The planning grants are expected to lead to full research programs which contribute to the long-term goals of building sustainable research capacity in LMICs to address nervous system development, function and impairment throughout life and to lead to diagnostics, prevention, and treatment strategies that are applicable worldwide.

NIH Brain Disorders in the Developing World: Research Across the Lifespan (R01)

Letters of Intent Due: April 16, 2010

Website: Grants.gov posting

Purpose: This Funding Opportunity Announcement (FOA) encourages grant applications proposing the development and conduct of innovative, collaborative research and research training projects, between High Income country (HIC) and low- to middle-income country (LMIC) scientists, on nervous system function and disorders throughout life, relevant to LMICs. The collaborative research programs are expected to contribute to the long-term goals of building sustainable research capacity in LMICs to address nervous system development, function and impairment throughout life and to lead to diagnostics, treatment and prevention strategies that are applicable worldwide.

New! CDMRP FY10 Breast Cancer Research Program (BCRP) - Idea Award

Idea Award Pre-Application Submission Deadline: April 21, 2010

Website: CDMRP posting

Purpose: Supports conceptually innovative, high-risk/high-reward research from all areas of basic, translational, clinical, behavioral, and epidemiological research. Innovation is the most important review criterion.

New! CDMRP FY10 Peer Reviewed Medical Research Program (PRMRP) - Clinical Trial Award

Clinical Trial Award Pre-Application Submission Deadline: April 22, 2010

Website: CDMRP posting

Purpose: Supports rapid implementation of clinical trials of novel interventions. Supports research that is responsive to the health care needs of the Armed Forces, their family members, and/or the U.S. veteran population. Must address an FY10 Topic Area. The FY10 PRMRP topic areas as provided by Congress are: Chronic Migraine and Post-traumatic Headache; Dystonia; Drug Abuse; Epilepsy; Fragile X Syndrome; Inflammatory Bowel Disease; Interstitial Cystitis; Listeria vaccine for infectious disease; Lupus; Mesothelioma; Neuroblastoma; Osteoporosis and related bone disease; Paget’s Disease; Pheochromocytoma; Polycystic Kidney Disease; Post-traumatic Osteoarthritis; Scleroderma; Social Work Research; Tinnitus.

New! CDMRP FY10 Peer Reviewed Medical Research Program (PRMRP) - Technology/Therapeutic Development Award

Technology/Therapeutic Development Award Pre-Application Submission Deadline: April 22, 2010

Website: CDMRP posting

Purpose: Product-oriented: Supports military-relevant health-related development of pharmacologic agents (drugs or biologicals), devices, and/or clinical guidance that has the potential to make a strong impact on patient care. Supports research that is responsive to the health care needs of the Armed Forces, their family members, and/or the U.S. veteran population. Must address an FY10 Topic Area. The FY10 PRMRP topic areas as provided by Congress are: Chronic Migraine and Post-traumatic Headache; Dystonia; Drug Abuse; Epilepsy; Fragile X Syndrome; Inflammatory Bowel Disease; Interstitial Cystitis; Listeria vaccine for infectious disease; Lupus; Mesothelioma; Neuroblastoma; Osteoporosis and related bone disease; Paget’s Disease; Pheochromocytoma; Polycystic Kidney Disease; Post-traumatic Osteoarthritis; Scleroderma; Social Work Research; Tinnitus.

DoD, Defense Advanced Research Projects Agency (DARPA) - Defense Sciences Office: Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Grant

Application Deadline: April 22, 2010

Website: Grants.gov posting

Purpose: DARPA seeks new methods for analysis and decoding of neural signals in order to understand how neural-based sensory stimulation could be applied to accelerate recovery from brain injury. Ultimately, it is desired to develop models of neural codes and temporal patterns that can provide an ability to interpret and predict changes in neural organization through plasticity at multiple scales of measurement.

New! NSF/FDA Scholar-in-Residence at FDA

Proposals Due: April 27, 2010

Website: NSF.gov posting

Purpose: The National Science Foundation (NSF), through the Directorate for Engineering's Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET), and the U.S. Food and Drug Administration (FDA), through its Center for Devices and Radiological Health (CDRH) have established the NSF/FDA Scholar-in-Residence Program at FDA. This program comprises an interagency partnership for the investigation of scientific and engineering issues concerning emerging trends in medical device technology. This partnership is designed to enable investigators in science, engineering, and mathematics to develop research collaborations within the intramural research environment at the FDA.

NIH/NCI Application and Early Stage Development of Emerging Technologies in
Cancer Research (R21)

Letters of Intent Receipt Date(s): April 27, 2010; August 30, 2010
Application Due Date(s): May 27, 2010; September 30, 2010

Website: Grants.gov posting

Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications that propose exploratory research projects on the initial application of emerging analytical technologies as laboratory or clinical tools. An “emerging technology” is defined as one that has passed the initial developmental stage, but has not yet been evaluated within the context of its intended use. Projects proposed in response to this FOA should have the potential to produce a major impact in a broad area of cancer-relevant research. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits R21 applications that have high potential impact and allows for an element of technical risk; preliminary data are not required. All projects must include quantitative milestones (i.e. technical metrics that determine whether the specific aims have been accomplished). Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation and will be returned as non-responsive. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

NIH/NCI Innovative Technology Development for Cancer Research (R21)

Letters of Intent Receipt Date(s): April 27, 2010; August 30, 2010
Application Due Date(s): May 27, 2010; September 30, 2010

Website: Grants.gov posting

Purpose: This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing technically innovative feasibility studies focused on early stage development of cancer-relevant technologies. If successful, these technologies would accelerate the research and understanding of basic cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits R21 applications and is suitable for projects at their inception, conceptual or idea based, where technical feasibility of the proposed technology or methodology has not yet been established. The R21 mechanism requires high potential impact and allows for an element of technical risk; projects proposed in response to this FOA may reflect this level of risk but must have concurrent potential to produce a major impact in a broad area of cancer-relevant research. All projects must include quantitative milestones (i.e. technical metrics that determine whether the specific aims have been accomplished). Projects proposing to use technology that is already established or projects where the novelty resides in the biological or clinical question being pursued are examples of topics not appropriate for this solicitation and will be returned as non-responsive. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

NIH/NCI Validation and Advanced Development of Emerging Technologies
for Cancer Research (R33)

Letters of Intent Receipt Date(s): April 27, 2010; August 30, 2010
Application Due Date(s): May 27, 2010; September 30, 2010

Website: NIH posting

Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing research projects on the advanced development of emerging molecular and cellular analysis technologies through technical/analytical validation in an appropriate cancer-relevant biological system. An “emerging technology” is defined as one that has passed the pilot developmental stage and shows promise, but has not yet been evaluated within the context of its intended use. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits R33 applications; this mechanism is suitable for projects where “proof-of-principle” of the proposed technology or methodology has been established and supportive preliminary data are available. Projects proposed to this FOA should reflect the potential to produce a major impact in a broad area of cancer-relevant research. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation and will be returned as non-responsive. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

New! NIH Investigator Initiated Multi-Site Clinical Trials (Collaborative R01)

Application Submission Window: May 5 - June 5, 2010

Website: NIH.gov posting

Purpose: The purpose of this Funding Opportunity Announcement is to provide a vehicle for submitting grant applications for investigator-initiated multi-site Phase II or Phase III randomized, controlled clinical trials. The trials may address any research question related to the mission and goals of NHLBI and may test clinical or behavioral interventions. Investigators should consult the NHLBI’s Guidelines for Investigator Initiated Clinical Trials (http://www.nhlbi.nih.gov/funding/policies/clinical.htm) for more detailed instructions and information about multi-site clinical trial grant applications. Additional information about the mission, strategic plan and research interests of the NHLBI can be found at NHLBI’s website (http://www.nhlbi.nih.gov/index.htm).

New! NIH Centers of Research Translation (P50)

Letter of Intent Due: May 10, 2010; May 10, 2011

Website: NIH.gov posting

Purpose: This Funding Opportunity Announcement (FOA), issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), invites applications for Centers of Research Translation (CORT) (P50). It is expected that a CORT will have a disease-targeted translational theme with individual projects providing synergy for the theme, directed at elucidating the relevance of basic research to human disease in an area within the NIAMS mission. Two major features of the CORT program include: 1) the overarching aim of disease-specific research translation, and 2) the inclusion of resources and an administrative structure to facilitate research translation.

NSF Neural Systems

Application Deadline: July 12, 2010, Annually Thereafter

Website: NSF.gov posting

Purpose: The Neural Systems Cluster focuses on how complex functions arise from communication among the cellular elements of the nervous system and from interactions with other physiological systems and the environment. The Cluster encourages a systems biology approach to understand how emergent neural properties such as robustness, adaptability and resilience arise in the context of environmental, genetic and evolutionary influences.

Investigations may range over time scales from the physiological to the evolutionary. Studies may range in complexity from molecular and cellular processes to the behaviors that emerge from these processes and the feedback that these behaviors exert on the system. The use of comparative and evolutionary studies, as well as the development of novel theoretical, computational, and transdisciplinary approaches to guide and instruct experimental design, are particularly encouraged.

NSF Physiological and Structural Systems

Application Deadline: July 12, 2010, Annually Thereafter

Website: NSF.gov posting

Purpose: The Physiological and Structural Systems Cluster supports research aimed at furthering the understanding of organisms as integrated units of biological organization. The Cluster considers proposals focused on interacting physiological and structural systems, their environmental and evolutionary contexts, and how these components are constrained by their integration into the whole organism. Projects that use systems approaches to understand why particular patterns of architecture and regulatory control have emerged as general organismal properties are particularly encouraged. Understanding how and why emergent organismal properties such as robustness, adaptability and resilience arise in the context of environmental, genetic, biochemical and morphological variation are of interest. The Cluster encourages model building to augment traditional experimental approaches in order to guide research on complex functional networks. Multidisciplinary approaches to the study of organismal systems including research at the interfaces of biology, physics, chemistry, mathematics, computer science and engineering are encouraged in each of the following areas: Symbiosis, Defense and Self-recognition; Processes, Structures and Integrity; Organism-Environment Interactions.

New! NIH Institutional Clinical and Translational Science Award (U54)

Letter of Intent Due: September 14, 2010

Website: NIH.gov posting

Purpose: The Clinical and Translational Science Award (CTSA) initiative assists institutions to create an integrated academic home for Clinical and Translational Science that has the resources to train and advance multi- and inter-disciplinary investigators and research teams with access to innovative research tools and information technologies that apply new knowledge and techniques to patient care. Clinical and Translational Science Awards (CTSAs) attract basic, translational, and clinical investigators, community clinicians, clinical practices, networks, professional societies, and industry to develop new professional interactions, programs, and research projects. Through innovative advanced degree programs, CTSAs foster the discipline of Clinical and Translational Science that is broader and deeper than their separate components (definitions of Clinical and Translational Science are provided in Section I of this posting).

HHS, NIH: In vivo Cellular and Molecular Imaging Centers (ICMICs) (P50) Grant

Application Submission Windows:
Letters of Intent Deadline(s): September 28, 2010; September 28, 2011
Application Deadline(s): October 28, 2010; October 28, 2011

Website: Grants.gov posting

Purpose: The program will fund the 5-year P50 ICMIC grants to support interdisciplinary scientific teams conducting cutting-edge cancer molecular imaging research. ICMIC funding is designed to: (1) support innovative cancer molecular imaging research projects; (2) support unique core facilities; (3) enable the awardees to initiate pilot research in new promising directions; and (4) provide interdisciplinary career development opportunities for investigators new to the field of molecular cancer imaging

HHS, NIH: Rapid Assessment Post-Impact of Disaster Grants (R03) & (R21)

Application Submission Window: June 22, 2009 - April 22, 2012

Website: Grants.gov (R03 grant) posting, award ceiling $50,000.

Grants.gov (R21 grant) posting, award ceiling $200,000.

Purpose: These grants are to provide a rapid funding mechanism for research on the post-impact of disasters, in order to permit access to a disaster area in the immediate aftermath of the event.

AHRQ Grant Program for Large or Recurring Conferences (R13)

Application Submission Window: November 12, 2009 - January 7, 2013

Website: Grants.gov posting

Purpose: The Agency for Healthcare Research and Quality (AHRQ), announces its continued interest in supporting conferences through its Large or Recurring Grant Program for Conference Support. AHRQ seeks to support conferences that help to further its mission to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. The types of conferences eligible for support include: 1) Research development - conferences where issues or challenges in the practice and delivery of health care are defined and a research agenda or strategy for studying them is developed; 2) Research design and methodology - conferences where methodological and technical issues of major importance to the field of health services research are addressed or new designs and methodologies are developed; 3) Dissemination and implementation - conferences where research findings and evidence-based information and tools are summarized, communicated and used by organizations and individuals that have the capability to use the information to improve the outcomes, quality, access to, and cost and utilization of health care services; and/or, 4) Research training, infrastructure and career development -conferences where faculty, trainees and students are brought together with stakeholders to develop, share or disseminate research products, experiences, curricula, syllabi, or training competencies. AHRQ is especially interested in supporting conferences that include plans for disseminating complimentary conference materials and products beyond the participants attending the event. Such strategies might include, but are not limited to, submitting articles for publication, posting information on a Web site, and seeking formal opportunities to discuss conference information with others.

AHRQ Partnerships in Implementing Patient Safety II (R18)

Application Submission Window: December 25, 2009 - January 8, 2013

Website: Grants.gov posting

Purpose: The purpose of this Funding Opportunity (FOA) is to support Research Demonstration and Dissemination (R18) grant applications from organizations that will implement safe practice interventions that demonstrate evidence of reducing or eliminating medical errors, risks, hazards, and harms associated with the process of health care. These 24 month implementation projects will inform AHRQ, providers, patients, payers, policy makers, and the public about how safe practice interventions can be successfully implemented in diverse health care settings and lead to safer and better health care for all Americans. This FOA follows the release of an earlier FOA in 2005 that resulted in the release of successful implementation projects and toolkits available to the public. Background information on the earlier FOA can be found at http://grants1.nih.gov/grants/guide/FOA-files/FOA-HS-05-012.html. Examples of and Information on projects from the initial Partnerships in Implementing Patient Safety FOA can be found at http://www.ahrq.gov/qual/pips/.